Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MO2DIFY: Vadadustat Maintenance in Hemodialysis Anemia
NCT04313153Phase 3Completed
- Sponsor
- Akebia Therapeutics
- Start
- May 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of vadadustat in anemia of chronic kidney disease (CKD-A), sponsored by Akebia Therapeutics. Started May 2020; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04313153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04313153.